Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siraj M Ali

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
The Journal of Biological Chemistry|April 6, 2005
Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif siteSiraj M Ali, David M Sabatini
Cancer|November 23, 2017
Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assaysSiraj M Ali, Jeffrey S Ross, Kai Wang
Current Opinion in Cell Biology|October 18, 2005
Growing roles for the mTOR pathwayDos D Sarbassov, Siraj M Ali, David M Sabatini
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
High MET amplification level as a resistance mechanism to osimertinib (AZD9291) in a patient that symptomatically responded to crizotinib treatment post-osimertinib progressionSai-Hong Ignatius Ou, Nikita Agarwal, Siraj M Ali
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2018
WAC/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung CarcinomaVamsidhar Velcheti, Russell Madison, Siraj M Ali, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2016
Acquired ALK L1152R Mutation Confers Resistance to Ceritinib and Predicts Response to AlectinibNishan Tchekmedyian, Siraj M Ali, Vincent A Miller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2018
EGFR-RAD51 Fusion: A Targetable Partnership Originated from the Tumor Evolution?Luis E Raez, Joseph A Pinto, Alexa B Schrock, et al.
European Urology|January 30, 2015
Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 MutationSiraj M Ali, Vincent A Miller, Jeffrey S Ross, et al.
Science (New York, N.Y.)|February 19, 2005
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complexD D Sarbassov, David A Guertin, Siraj M Ali, et al.
Gynecologic Oncology Reports|March 24, 2017
A recurrent endometrial stromal sarcoma harbors the novel fusion <i>JAZF1-BCORL1</i>Allison J Allen, Siraj M Ali, Kyle Gowen, et al.
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
The Journal of Biological Chemistry|April 6, 2005
Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif siteSiraj M Ali, David M Sabatini
Cancer|November 23, 2017
Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assaysSiraj M Ali, Jeffrey S Ross, Kai Wang
Current Opinion in Cell Biology|October 18, 2005
Growing roles for the mTOR pathwayDos D Sarbassov, Siraj M Ali, David M Sabatini
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
High MET amplification level as a resistance mechanism to osimertinib (AZD9291) in a patient that symptomatically responded to crizotinib treatment post-osimertinib progressionSai-Hong Ignatius Ou, Nikita Agarwal, Siraj M Ali
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2018
WAC/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung CarcinomaVamsidhar Velcheti, Russell Madison, Siraj M Ali, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2016
Acquired ALK L1152R Mutation Confers Resistance to Ceritinib and Predicts Response to AlectinibNishan Tchekmedyian, Siraj M Ali, Vincent A Miller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2018
EGFR-RAD51 Fusion: A Targetable Partnership Originated from the Tumor Evolution?Luis E Raez, Joseph A Pinto, Alexa B Schrock, et al.
European Urology|January 30, 2015
Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 MutationSiraj M Ali, Vincent A Miller, Jeffrey S Ross, et al.
Science (New York, N.Y.)|February 19, 2005
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complexD D Sarbassov, David A Guertin, Siraj M Ali, et al.
Gynecologic Oncology Reports|March 24, 2017
A recurrent endometrial stromal sarcoma harbors the novel fusion <i>JAZF1-BCORL1</i>Allison J Allen, Siraj M Ali, Kyle Gowen, et al.
Pageof 27